Clinical Trial

Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique

Study acronym: REDOCH
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 15, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
The HIV infection not fully controlled, despite being under antiretroviral treatment, could make virus resistance against the antiretroviral treatments, making hardest the well control of HIV infection. The purpose of this research study is to confirm or deny if a not fully good controlled HIV infection could develop virus resistance against antiretroviral drugs that can difficult the good control of the HIV infection.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-09-18; most recent amendment 2025-05-14.
Status change: Not Yet Recruiting → Recruiting 2024-11-11
Trial Details
NCT Number NCT06607588
Lead Sponsor Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
Conditions HIV, HIV Antiretroviral Therapy (ART) Adherence
Enrollment 200 participants
Start Date 2024-10-25
Primary Completion 2026-04 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2025-05-15